序号 |
标题 |
次数 |
作者 |
发布时间 |
85951 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
146 |
zcy |
2024-11-22 |
85952 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
78 |
kx |
2024-11-22 |
85953 |
DOTA-cyclo(RGDfK);DOTA-RGD |
93 |
wyh |
2024-11-22 |
85954 |
CuAAC修饰的DOTAZA 齐岳定制 |
114 |
zcy |
2024-11-22 |
85955 |
1039726-31-2,DOTA-JR-11 |
78 |
kx |
2024-11-22 |
85956 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
122 |
zcy |
2024-11-22 |
85957 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
93 |
zyl |
2024-11-22 |
85958 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
91 |
zcy |
2024-11-22 |
85959 |
DOTA-CH2-Ph-azide(HCl salt) |
86 |
kx |
2024-11-22 |
85960 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
106 |
zyl |
2024-11-22 |
85961 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
94 |
kx |
2024-11-22 |
85962 |
CAS:834870-39-2 DOTA series |
101 |
zyl |
2024-11-22 |
85963 |
DOTA-cyclo(RGDfK);DOTA-RGD |
95 |
wyh |
2024-11-22 |
85964 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
90 |
kx |
2024-11-22 |
85965 |
DTPA-bis anhydride,二亚乙基三胺五乙酸二酐 |
107 |
wyh |
2024-11-22 |
85966 |
NOTA-PEG5000-Mal ;NOTA PEG5 马来酰亚胺 |
77 |
wyh |
2024-11-22 |
85967 |
DOTA-E「c(RGDfK)2」 |
84 |
kx |
2024-11-22 |
85968 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
102 |
zcy |
2024-11-22 |
85969 |
DOTA-E[c(RGDfK)2]的应用领域 |
104 |
kx |
2024-11-22 |
85970 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
82 |
zcy |
2024-11-22 |
85971 |
DOTA-NHS |
147 |
kx |
2024-11-22 |
85972 |
p-SCN-Bn-DTPA,102650-30-6,1-(4-异硫氰酸酯)二乙炔三胺 |
87 |
wyh |
2024-11-22 |
85973 |
NOTA-PEG-RGD |
81 |
kx |
2024-11-22 |
85974 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸;137076-54-1 |
117 |
wyh |
2024-11-22 |
85975 |
DOTA-PEG-CRGD的结构组成、应用领域 |
82 |
kx |
2024-11-22 |
85976 |
DOTA-MWCNT-Gd DOTA钆配合物修饰多壁碳纳米管 |
85 |
zcy |
2024-11-22 |
85977 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
81 |
kx |
2024-11-22 |
85978 |
DOTA-四聚乙二醇-甲基四嗪 |
99 |
zyl |
2024-11-22 |
85979 |
DOTA-奥曲肽,DOTA-octreotide |
113 |
kx |
2024-11-22 |
85980 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 |
70 |
zyl |
2024-11-22 |
85981 |
127985-74-4 ,p-SCN-Bn-DOTA |
101 |
kx |
2024-11-22 |
85982 |
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2,250612-06-7 |
83 |
wyh |
2024-11-22 |
85983 |
DOTA探针分子DOTA-EM7 |
83 |
kx |
2024-11-22 |
85984 |
DOTA-四聚乙二醇-二苯并环辛炔;DSPE-PEG4-DBCO |
88 |
wyh |
2024-11-22 |
85985 |
DOTA缀合RAWVAWR-NH2 DOTA-RAWVAWR-NH2 |
86 |
zcy |
2024-11-22 |
85986 |
DOTA-FYLEHPSGGLAV-OH |
80 |
kx |
2024-11-22 |
85987 |
Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester),479081-06-6 |
76 |
wyh |
2024-11-22 |
85988 |
锕系元素(ⅲ)-DOTA配合物 Actinide(III)-DOTA Complexes |
93 |
zcy |
2024-11-22 |
85989 |
DOTA-PEG8-NHCO-MeTz |
80 |
zyl |
2024-11-22 |
85990 |
909024-55-1,DOTA-cyclo(RGDfK) acetate |
84 |
kx |
2024-11-22 |
85991 |
DOTA生物素肌氨酸;DOTA-Biotin-Sarcosine |
71 |
wyh |
2024-11-22 |
85992 |
环烯配体DOTA衍生物AspDOTA、GlyDOTA和PropDOTA |
131 |
zcy |
2024-11-22 |
85993 |
Eu-DOTA-氮氧化合物 Eu-DOTA-NOx |
95 |
zcy |
2024-11-22 |
85994 |
DOTATATE |
101 |
kx |
2024-11-22 |
85995 |
cyclo(RGDFK(DOTA)) |
73 |
wyh |
2024-11-22 |